Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2 (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02312063
What this trial is testing

Dietary Impacts on Glucose-lowering Effects of Sitagliptin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Kansai Electric Power Hospital 48
Not applicableStudy completedNCT06289387
What this trial is testing

Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes

Who this might be right for
Type2diabetes
Medanta, The Medicity, India 1,000
Not applicableActive Not RecruitingNCT07783893
What this trial is testing

E-Health Literacy Intervention for Bangladeshi Migrants With Type 2 Diabetes in Italy

Who this might be right for
Type 2 DiabetesDiabete Mellitus
Marche Region Regional Health Agency 50
Not applicableUnknownNCT06142006
What this trial is testing

The Diabetes Staging System in Patient Aligned Care Teams

Who this might be right for
Diabetes MellitusType 2 Diabetes
Durham VA Medical Center 120
Large-scale testing (Phase 3)UnknownNCT01257334
What this trial is testing

Patients With Type 2 Diabetes Mellitus With Insufficient Glycaemic Control Despite Treatment With Metformin Alone or Metformin in Combination With a Sulfonylurea

Who this might be right for
Type 2 Diabetes
Taipei Medical University WanFang Hospital 1,390
Not applicableUnknownNCT01776099
What this trial is testing

Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
German Institute of Human Nutrition 60
Post-approval studies (Phase 4)UnknownNCT00427271
What this trial is testing

Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus Patients

Who this might be right for
Diabetes MellitusMicroalbuminuria
Hospital de Clinicas de Porto Alegre 20
Not applicableUnknownNCT01107132
What this trial is testing

Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusNon-Proliferative Diabetic RetinopathyDiabetic Macular Edema
Soroka University Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT00605787
What this trial is testing

TTA in Treatment of Diabetes and Dyslipidemia

Who this might be right for
Type 2 Diabetes MellitusDyslipidemia
Haukeland University Hospital 16
Testing effectiveness (Phase 2)Study completedNCT00638716
What this trial is testing

Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
ConjuChem 122
Not applicableStudy completedNCT03291171
What this trial is testing

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes

Who this might be right for
Chronic Disease
University Ghent 56
Post-approval studies (Phase 4)Looking for participantsNCT05164263
What this trial is testing

Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study

Who this might be right for
Type II Diabetes MellitusEfficacy, SelfSafety Issues
Getz Pharma 2,000
Testing effectiveness (Phase 2)Study completedNCT00422487
What this trial is testing

Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Gilead Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT02053116
What this trial is testing

A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug Given With Canagliflozin In Adults With Type 2 Diabetes Mellitus Taking Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 8
Not applicableStudy completedNCT00412906
What this trial is testing

Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls

Who this might be right for
HealthyType 2 DiabetesEndotoxemia
Rigshospitalet, Denmark 48
Not applicableStudy completedNCT01934673
What this trial is testing

A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Malaysia

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 1,668
Post-approval studies (Phase 4)Study completedNCT02637973
What this trial is testing

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNon-alcoholic Fatty Liver Disease
The Deutsche Diabetes Forschungsgesellschaft e.V. 84
Post-approval studies (Phase 4)Ended earlyNCT00559286
What this trial is testing

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels

Who this might be right for
Arterial HypertensionDiabetes Mellitus Type 2 IRC or NIR
RWTH Aachen University 40
Not applicableStudy completedNCT01654341
What this trial is testing

Multi-Modal Intervention In Frail And Prefrail Older People With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Hospital Universitario Getafe 986
Not applicableStudy completedNCT00714441
What this trial is testing

Reducing Distress and Improving Self-Care in Diabetes

Who this might be right for
Diabetes Type 2
University of California, San Francisco 392
Next Page